grepcent public filings, reorganized for comparison

Addus HomeCare Corp (ADUS)

CIK: 0001468328. SIC: 8082 Services-Home Health Care Services. Latest 10-K as of: 2026-02-24.

SIC breadcrumb: Services > SIC Major Group 80 > SIC 8082 Services-Home Health Care Services

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1468328. Latest filing source: 0001437749-26-005352.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-24 · accession 0001437749-26-005352 · source: SEC companyfacts

Revenue
1,422,530,000 USD verified
Net income
95,910,000 USD verified
Assets
1,437,308,000 USD verified
Free cash flow
103,788,000 USD computed
Net margin
6.74% computed
Operating margin
9.74% computed
Revenue YoY
+23.21% computed
ROE
8.84% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

ADUS ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 80; per-ratio N printed.ADUS ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 80; per-ratio N printed.RatioADUSPeer medianPercentileNNet margin6.7%3.2%7356Operating margin9.7%5.5%6851Revenue growth23.2%11.8%7757FCF margin7.3%5.4%5748ROE8.8%7.9%5653ROA6.7%2.8%7558Liabilities / equity0.321.131354Current ratio1.801.635858

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 80 SIC Major Group 80, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue1,422,530,000USD20252026-02-24
Net income95,910,000USD20252026-02-24
Assets1,437,308,000USD20252026-02-24

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-24. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001468328.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric20152016201720182019202020212022202320242025
Revenue400,929,000425,994,000516,647,000648,791,000764,775,000864,499,000951,120,0001,058,651,0001,154,599,0001,422,530,000
Net income12,160,00011,953,00016,433,00025,237,00033,133,00045,126,00046,025,00062,516,00073,598,00095,910,000
Operating income15,476,00025,253,00022,827,00034,752,00044,507,00065,936,00068,737,00090,956,000102,691,000138,615,000
Gross profit106,336,000115,875,000136,804,000179,238,000226,237,000269,848,000299,739,000339,876,000375,021,000461,874,000
Diluted EPS1.071.031.331.772.082.812.843.834.235.22
Operating cash flow-743,00052,771,00033,203,00012,019,000109,411,00039,488,000105,110,000112,247,000116,434,000111,507,000
Capital expenditures1,712,0003,616,0005,349,0004,621,0006,831,0004,645,0008,300,0009,454,0006,050,0007,719,000
Assets229,864,000271,691,000348,094,000636,748,000892,582,000947,585,000937,994,0001,024,426,0001,412,634,0001,437,308,000
Liabilities72,102,00095,382,00079,603,000161,156,000373,906,000373,241,000304,454,000317,732,000442,142,000352,005,000
Stockholders' equity154,674,000170,337,000268,491,000475,592,000518,676,000574,344,000633,540,000706,694,000970,492,0001,085,303,000
Cash and cash equivalents4,104,0008,013,00053,754,00070,406,000111,714,000145,078,000168,895,00079,961,00064,791,00098,911,000
Free cash flow-2,455,00049,155,00027,854,0007,398,000102,580,00034,843,00096,810,000102,793,000110,384,000103,788,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric20152016201720182019202020212022202320242025
Net margin3.03%2.81%3.18%3.89%4.33%5.22%4.84%5.91%6.37%6.74%
Operating margin3.86%5.93%4.42%5.36%5.82%7.63%7.23%8.59%8.89%9.74%
Return on equity7.86%7.02%6.12%5.31%6.39%7.86%7.26%8.85%7.58%8.84%
Return on assets5.29%4.40%4.72%3.96%3.71%4.76%4.91%6.10%5.21%6.67%
Liabilities / equity0.470.560.300.340.720.650.480.450.460.32
Current ratio2.642.832.863.082.002.761.701.381.671.80

Industry Peer Context

Each number-line places ADUS against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

ADUS Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8082; peer count 6.ADUS Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8082; peer count 6.6 SIC peersMin -2.2%Median 5.2%Max 10.5%ADUS 6.7%

Operating margin peer context

ADUS Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8082; peer count 6.ADUS Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8082; peer count 6.6 SIC peersMin 2.3%Median 7.9%Max 13.4%ADUS 9.7%

ROE peer context

ADUS ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8082; peer count 6.ADUS ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8082; peer count 6.6 SIC peersMin -4.7%Median 12.9%Max 115.7%ADUS 8.8%

ROA peer context

ADUS ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8082; peer count 6.ADUS ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8082; peer count 6.6 SIC peersMin -1.6%Median 6.3%Max 17.2%ADUS 6.7%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Income statement bridge from reported figures

ADUS FY2025 income statement bridge from reported figures.ADUS FY2025 income statement bridge from reported figures.ADUS income bridgeFY2025: revenue to net incomeSource: SEC companyfacts FY2025.Income statement bridgeReported amount$0.0B$1.0B$2.0B$1.4BRevenue-$960.7MCost$461.9MGross-$323.3MOpEx$138.6MOperating-$42.7MOther/tax$95.9MNet income

Figure provenance: SEC companyfacts FY 2025. Revenue: accession 0001437749-26-005352; concept RevenueFromContractWithCustomerExcludingAssessedTax; source concepts us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Gross profit: accession 0001437749-26-005352; concept GrossProfit; source concepts us-gaap:GrossProfit | Operating income: accession 0001437749-26-005352; concept OperatingIncomeLoss; source concepts us-gaap:OperatingIncomeLoss | Net income: accession 0001437749-26-005352; concept NetIncomeLoss; source concepts us-gaap:NetIncomeLoss

Free cash flow = operating cash flow - capital expenditures

ADUS FY2025 free cash flow bridge from reported figures.ADUS FY2025 free cash flow bridge from reported figures.ADUS free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$111.5MOperating cash flow-$7.7MCapex$103.8MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001437749-26-005352; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001437749-26-005352; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001437749-26-005352; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

ADUS revenue, last 5 periods. Source: SEC companyfacts FY2025.ADUS revenue, last 5 periods. Source: SEC companyfacts FY2025.ADUS RevenueLatest point: FY2025 = $1.4BSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

ADUS net income, last 5 periods. Source: SEC companyfacts FY2025.ADUS net income, last 5 periods. Source: SEC companyfacts FY2025.ADUS Net incomeLatest point: FY2025 = $95.9MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

ADUS operating income, last 5 periods. Source: SEC companyfacts FY2025.ADUS operating income, last 5 periods. Source: SEC companyfacts FY2025.ADUS Operating incomeLatest point: FY2025 = $138.6MSource: SEC companyfacts FY2025.Fiscal yearOperating income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

ADUS gross profit, last 5 periods. Source: SEC companyfacts FY2025.ADUS gross profit, last 5 periods. Source: SEC companyfacts FY2025.ADUS Gross profitLatest point: FY2025 = $461.9MSource: SEC companyfacts FY2025.Fiscal yearGross profit$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: GrossProfit. Source concepts: us-gaap:GrossProfit.

ADUS diluted eps, last 5 periods. Source: SEC companyfacts FY2025.ADUS diluted eps, last 5 periods. Source: SEC companyfacts FY2025.ADUS Diluted EPSLatest point: FY2025 = $5.22/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$3.00/share$6.00/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

ADUS operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.ADUS operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.ADUS Operating cash flowLatest point: FY2025 = $111.5MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

ADUS capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.ADUS capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.ADUS Capital expendituresLatest point: FY2025 = $7.7MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

ADUS assets, last 5 periods. Source: SEC companyfacts FY2025.ADUS assets, last 5 periods. Source: SEC companyfacts FY2025.ADUS AssetsLatest point: FY2025 = $1.4BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: Assets. Source concepts: us-gaap:Assets.

ADUS liabilities, last 5 periods. Source: SEC companyfacts FY2025.ADUS liabilities, last 5 periods. Source: SEC companyfacts FY2025.ADUS LiabilitiesLatest point: FY2025 = $352.0MSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

ADUS stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.ADUS stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.ADUS Stockholders' equityLatest point: FY2025 = $1.1BSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

ADUS cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2024.ADUS cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2024.ADUS Cash and cash equivalentsLatest point: FY2024 = $98.9MSource: SEC companyfacts FY2024.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0MFY2020FY2021FY2022FY2023FY2024

Figure provenance: SEC companyfacts. Latest point: FY 2024 ended 2024-12-31; accession 0000950170-25-026747; filed 2025-02-25. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

ADUS free cash flow, last 5 periods. Source: SEC companyfacts FY2025.ADUS free cash flow, last 5 periods. Source: SEC companyfacts FY2025.ADUS Free cash flowLatest point: FY2025 = $103.8MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001437749-26-005352; filed 2026-02-24. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

10 tracked differences above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period.

View the filing-by-filing ledger →

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-04. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001468328.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q32022-09-300.71reported discrete quarter
2023-Q12023-03-310.78reported discrete quarter
2023-Q22023-06-300.91reported discrete quarter
2023-Q32023-09-30270,721,00015,411,0000.95reported discrete quarter
2023-Q42023-12-31276,351,00019,578,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-03-31280,746,00015,830,0000.97reported discrete quarter
2024-Q22024-06-30286,922,00018,079,0001.10reported discrete quarter
2024-Q32024-09-30289,787,00020,163,0001.10reported discrete quarter
2024-Q42024-12-31297,144,00019,526,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-03-31337,708,00021,228,0001.16reported discrete quarter
2025-Q22025-06-30349,443,00022,052,0001.20reported discrete quarter
2025-Q32025-09-30362,301,00022,848,0001.24reported discrete quarter
2025-Q42025-12-31373,078,00029,782,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-31363,611,00025,069,0001.36reported discrete quarter
2026-Q22026-06-30377,417,00027,607,0001.49reported discrete quarter

Quarterly Charts

ADUS quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.ADUS quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.ADUS Quarterly RevenueLatest point: 2026-Q2 = $377.4MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Revenue$0.0B$250.0M$500.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001437749-26-025678; filed 2026-08-04. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

ADUS quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.ADUS quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.ADUS Quarterly Net incomeLatest point: 2026-Q2 = $27.6MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Net income$0.0B$125.0M$250.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001437749-26-025678; filed 2026-08-04. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

ADUS quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.ADUS quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.ADUS Quarterly Diluted EPSLatest point: 2026-Q2 = $1.49/shareSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Diluted EPS (USD/share)$0.00/share$1.00/share$2.00/share2022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001437749-26-025678; filed 2026-08-04. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read ADUS's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read ADUS's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001437749-26-025678.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-08-04. Report date: 2026-06-30.

ITEM 2.       MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements about our business and operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should,” and similar expressions are intended to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the impact of macroeconomic conditions, including inflation and interest rates, legislative and political developments, including federal government shutdowns, any lapse in appropriations and any hold on or cancellation of congressionally authorized spending or interruptions in the distribution of government funds, trade policies and tensions, including changes in, or the imposition of, tariffs and/or trade barriers and the economic impacts, volatility and uncertainty resulting therefrom, and the potential adverse effects of current conditions; business disruptions due to inclement weather, natural disasters, acts of terrorism, military conflicts, pandemics, civil insurrection or social unrest; changes in operational and reimbursement processes and payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations’ policies and payment rates, and the timeliness of reimbursements received under government programs; the implementation of new, and possible changes to existing, federal and state laws or regulations, or our failure to comply with such laws or regulations or comply on a timely basis; the impact of decisions of the U.S. Supreme Court regarding the actions of federal agencies; changes in the executive branch of the federal government; changes in the structure and administration of, and funding for, federal and state agencies and programs; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to overall economic conditions and deficit or spending reduction measures by federal and state governments, and our expectations regarding these changes; cost containment initiatives undertaken by federal and state governmental and other third-party payors; our ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; our ability to integrate and manage our information systems; any security breaches, cyber-attacks, loss of data, or cybersecurity threats or incidents, and any actual or perceived failures to comply with legal requirements related to the privacy of confidential consumer data and other sensitive information; the size and growth of the markets for our services, including our expectations regarding the markets for our services; eligibility standards, moratoria on new provider enrollments and limits on services imposed through legislation or by governmental agencies or other third-party payors; the potential for litigation, audits, and investigations; discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating, and integrating acquisition opportunities and expanding into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of potential acquisitions; the effectiveness, quality, and cost of our services; our ability to successfully execute our growth strategy; changes in tax rates;  and various other matters, many of which are beyond our control. In addition, these forward-looking statements are subject to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2025, filed with the SEC. You should carefully review all of these factors. Moreover, our business may be materially adversely affected by factors that are not currently known to us, by factors that we currently consider immaterial or by factors that are not specific to us, such as general economic conditions. These forward-looking statements were based on information, plans, and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes, except as may be required by law.

22

Table of Contents

Overview

We are a home care services provider operating three segments: personal care, hospice, and home health. Our services are principally provided in-home under agreements with federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care organizations accounted for 38.6% and 36.7% of our net service revenues during the three months ended June 30, 2026 and 2025, respectively, and 38.4% and 36.5% of our net service revenues during the six months ended June 30, 2026 and 2025, respectively.

A summary of certain consolidated financial results is provided in the table below.

For the Three Months Ended June 30,For the Six Months Ended June 30,
2026202520262025
Net service revenues by segment:(Amounts in Thousands)(Amounts in Thousands)
Personal care$295,995$269,183$577,089$527,469
Hospice64,24762,212130,032123,649
Home health17,17518,04833,90736,033
Total net service revenue$377,417$349,443$741,028$687,151
Net income$27,607$22,052$52,676$43,280

As of June 30, 2026, we provided our services in 24 states through 264 offices. Our personal care segment also includes staffing services, with clients including assisted living facilities, nursing homes, and hospice facilities.

Acquisitions

In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets, with the goal of having all three levels of in-home care in our markets or facilitating our entry into new markets where in-home care has been moving to managed care organizations or that present other strategic opportunities.

On January 1, 2025, the Company completed its acquisition of its Jacksonville affiliate (the “Jacksonville Acquisition”), for approximately $0.8 million, with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.

On March 1, 2025, the Company completed its acquisition of the assets of Great Lakes Home Care Unlimited, LLC (the “Great Lakes Acquisition”), for $2.6 million, with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.

On August 1, 2025, the Company completed its acquisition of Helping Hands Home Care Service, Inc. (the “Helping Hands Acquisition”), for approximately $21.4 million, with funding through the Company’s revolving credit facility and available cash. With the Helping Hands Acquisition, the Company expanded its services within its personal care segment and entered the hospice and home health markets in Pennsylvania and recognized goodwill in its personal care segment of $19.0 million.

On October 1, 2025, the Company completed its acquisition of Gold Horses, LLC (the “Gold Horses Acquisition”), for approximately $7.4 million, with funding provided by available cash. With the Gold Horses Acquisition, the Company expanded its services within its personal care segment in Texas and recognized goodwill in its personal care segment of $7.4 million.

On May 1, 2026, the Company completed its acquisition of HomeCourt Home Care (the “HomeCourt Acquisition”), for approximately $12.2 million, with funding provided by available cash. With the HomeCourt Acquisition, the Company expanded its services within its personal care segment to Indiana and recognized goodwill in its personal care segment of $11.3 million.

New York Asset Sale

Effective May 20, 2024, we entered into the New York Asset Sale. The Company entered into a consulting agreement with the purchaser, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale was occurring over time. In connection with this transaction, the Company ceased operations in New York. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture.

23

Table of Contents

Recruiting

As the labor market continues to be tight and unemployment remains at low levels, the competition for new caregivers, including skilled healthcare staff, and support staff continues to be significant. In addition, the United States economy continues to experience inflationary pressures. To the extent that we continue to experience a shortage of caregivers, it may hinder our ability to fully meet the continuing demand for both our non-clinical and clinical services.

Revenue by Payor and Significant States

Our payors are principally federal, state, and local governmental agencies and managed care organizations. The federal, state, and local programs under which the agencies operate are subject to legislative and budgetary changes and other risks that can influence reimbursement rates. We have experienced a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care.

Our revenue by payor and significant states by segment were as follows:

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001437749-26-005352. The complete FY 2025 MD&A is published at /company/ADUS/mda/fy2025/.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2026-02-24. Report date: 2025-12-31.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with our Consolidated Financial Statements and the related notes included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements about our business and operations. Our actual results may differ materially from those we currently anticipate as a result of the factors we describe under “Risk Factors” and elsewhere in this Annual Report on Form 10-K and other risks as well as other factors that are not currently known to us, that we currently consider immaterial or that are not specific to us, such as general economic conditions. The discussion of our financial condition and results of operations for the year ended December 31, 2024 compared to the year ended December 31, 2023, included in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) can be found in the Annual Report on Form 10-K for the year ended December 31, 2024.

Overview

We are a home care services provider operating three segments: personal care, hospice and home health. Our services are principally provided in-home under agreements with federal, state and local government agencies, managed care organizations, commercial insurers and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care revenues accounted for 37.0%, 34.8% and 36.6% of our revenue during the years ended December 31, 2025, 2024, and 2023 respectively.

A summary of certain consolidated financial and statistical data results for 2025, 2024 and 2023 are provided in the table below.

For the Years Ended December 31,
202520242023
(Amounts in Thousands, except States and Locations)
Net service revenues$1,422,530$1,154,599$1,058,651
Net income$95,910$73,598$62,516
Total assets$1,437,308$1,412,634$1,024,426
Adjusted EBITDA (1)$179,984$140,290$121,020
States served at period end232322
Locations at period end262258219
Column 1Column 2Column 3
(1)The Company defines adjusted EBITDA as earnings before net interest expense, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, restructuring and other non-recurring costs, the gain or loss on the sale of assets, the impairment of operating lease assets, the impact of New York retroactive rate increases, and the impact of New York accounts receivable settlements. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (“GAAP”). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. Additionally, our calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. Management believes that Adjusted EBITDA is useful to investors, management and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers. Additionally, we believe that Adjusted EBITDA is a measure widely used by securities analysts, investors and others to evaluate the financial performance of other public companies. The financial results presented in accordance with U.S. GAAP and a reconciliation of this non-GAAP measure included within this Annual Report on Form 10-K should be carefully evaluated.

43

Table of Contents

Acquisitions

In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets, with the goal of having all three levels of in-home care in our markets, or facilitating our entry into new markets where in-home care has been moving to managed care organizations.

On March 9, 2024, we completed the Upstate Acquisition for $0.4 million, with funding provided by available cash. With the Upstate Acquisition, the Company expanded its personal care segment in South Carolina.

On December 2, 2024, we completed the Gentiva Acquisition for approximately $353.6 million, with funding primarily provided by drawing on the Company’s revolving credit facility and a portion of the net proceeds of the Company’s public offering of common stock. With the Gentiva Acquisition, the Company expanded its services within its personal care segment in Arizona, Arkansas, California, and North Carolina, and entered the market in Missouri and Texas. The home health segment also was expanded in Tennessee.

On January 1, 2025, we completed the Jacksonville Acquisition for approximately $0.8 million, with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.

On March 1, 2025, we completed the Great Lakes Acquisition for $2.6 million, with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.

On August 1, 2025, we completed the Helping Hands Acquisition, for approximately $21.4 million, with funding through the Company’s revolving credit facility and available cash. With the Helping Hands Acquisition, the Company expanded its services within its personal care segment and entered the hospice and home health markets in Pennsylvania and recognized goodwill in its personal care segment of $19.0 million.

On October 1, 2025, we completed the Gold Horses Acquisition, for approximately $7.4 million, with funding provided by available cash. With the Gold Horses Acquisition, the Company expanded its services within its personal care segment in Texas and recognized goodwill in its personal care segment of $7.4 million.

Divestiture

Effective May 20, 2024, we entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $23.0 million in cash, subject to certain adjustments, including adjustments for future operating requirements (the “New York Asset Sale”). The purchase price included 50% cash consideration, paid out as an initial payment of $4.6 million and $6.9 million paid pro rata as a deferred payment as caregivers are transferred, and 50% in the form of contingent consideration for the Company’s New York Consumer Directed Personal Assistance Program (“CDPAP”) business. The Company entered into a consulting agreement with the purchaser effective May 20, 2024, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. The Company determined that the consulting agreement gave it the ability to control the business until October 2024, when the Company determined that it no longer controlled the business as it transferred more than 50% of the clients and caregivers and therefore qualified for sale consideration of the New York Asset Sale. As a result, the Company deconsolidated the results of its New York operations and recorded a gain on divestiture of $3.7 million during the year ended December 31, 2024. The gain was reflected within general and administrative expenses on the consolidated statement of operations.

44

Table of Contents

Revenue by Payor and Significant States

Our payor clients are principally federal, state and local governmental agencies and managed care organizations. The federal, state and local programs under which the agencies operate are subject to legislative, administrative and budgetary changes and other risks that can influence reimbursement rates. We have experienced a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care. Medicare advantage revenue is included within Medicare.

For the years ended December 31, 2025, 2024 and 2023, our revenue by payor and significant states by segment were as follows:

Personal Care
202520242023
Amount (in Thousands)% of Segment Net Service RevenuesAmount (in Thousands)% of Segment Net Service RevenuesAmount (in Thousands)% of Segment Net Service Revenues
State, local and other governmental programs$553,47550.8%$456,88553.3%$400,75350.4%
Managed care organizations501,52846.0376,60444.0367,55746.2
Private pay27,8712.615,5891.816,2682.0
Commercial insurance5,6090.55,5930.76,3210.8
Other7320.11,9100.23,8190.6
Total personal care segment net service revenues$1,089,215100.0%$856,581100.0%$794,718100.0%
Illinois$458,82842.1%$441,01251.5%$411,08151.7%
Texas216,71219.917,9362.0
New Mexico118,58810.9115,38113.5115,98614.6
New York71,7638.492,46911.6
All other states295,08727.1210,48924.6175,18222.1
Total personal care segment net service revenues$1,089,215100.0%$856,581100.0%$794,718100.0%

With the Jacksonville Acquisition, the Great Lakes Acquisition, the Helping Hands Acquisition and the Gold Horses Acquisition in 2025, the Company expanded its personal care services to consumers in the state of Florida, Michigan, Pennsylvania and Texas. With the acquisition of Upstate and the Gentiva Acquisition in 2024, the Company expanded its personal care services to consumers in the state of Arizona, Arkansas, California, Missouri, North Carolina, South Carolina and Texas.

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for ADUS

Indicators mapped to this company's SIC classification (industry 8082 Services-Home Health Care Services) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: US labor market, Growth & output, Government finances, Sector employment.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/ADUS.md · JSON record: /company/ADUS.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt